Sensory Seed is a spin-off dedicated to Health and Life Sciences using Circuit Seed’s novel, proprietary and technologically advanced “analog in scalable digital” circuitry.
The team has and will continue to create inventions and semiconductor subsystems to accelerate health and life sciences applications.
Sensory Seed has exclusive sub-licensing rights for the IP that it generates, and exclusive field of use and sub-licensing rights for Circuit Seed IP for Health and Life Sciences.
InventionShare is the investment partner for both Circuit Seed and Sensory Seed, and is the architect behind defining joint venture relationships and partners and assisting in their growth and accelerated execution.
Special Purpose Joint Ventures (SPJV) Opportunities
|Lab on a Chip||Deep analysis on small format “lab on a chip” technologies has identified a consistent weakness of analog processes limiting the effectiveness of these devices; running the analog process in Sensory Seed digital will provide much needed speed and accuracy with enhanced communications, all on a smaller footprint with lower power.|
|Water & Air Quality||Real time water quality readings from water faucets and throughout the water infrastructure. Adjacent opportunities in air quality sensing, from consumer to industrial and regional air and pollution movements.|
|Food Quality||Food supply quality sensing from farm production (livestock, plants, fish) through logistics, distribution, value add processes at any stage through to consumption. Fly-over drone sensing through to smart fridges, and everything in between.|
|Skin as a Platform||Transdermal surface based measurements systems to contribute diagnostically in a wide range of areas such as EP studies, diabetics, post-op monitoring, pre- and post-transplant care, etc.|
|Hearing Optimization||Personalization and optimization for impairment – sporting events, entertainment, conferences, social events, crowds, etc.|
|Biosensors||Detection of various health and life sciences conditions using chemistry, biochemistry and molecular tag interaction followed by integrated data acquisitions and analysis using the CiFET’s analog-in-digital capability. Biosensors are, in part, implemented in other projects; the evolution of these systems will lead to the evolution of the others.|
|Pacemakers||Incorporate new capabilities to capture data such as cardioactive drug impact assessment, tissue condition, trajectory tracking congestive heart failure, provide a cardiac contractility index, and more.|
|Implantable Electrodes||Cardiac monitoring systems that provide complex information such as the cardio active drug efficacy, CHF (Congestive Heart Failure) trajectory, anomalous cardiac events, tissue condition monitor for monitoring post major organ surgery or transplant).|
Other Founding Shareholders and Advisory Board